This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
The facility will manufacture tablets, capsules, and injections for the oncology segment
The report underscores significant advancements in healthcare delivery, showcasing how GenAI facilitates improved diagnostic accuracy, operational efficiency and patient engagement
Combination shows consistent benefit across prespecified post-progression outcomes
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
These approvals mark significant progress for Venus Remedies in expanding its market presence
The investment will catalyse various components of the IndiaAI Mission
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Subscribe To Our Newsletter & Stay Updated
